Ajmalicin
Structural formula | ||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
General | ||||||||||||||||
Surname | Ajmalicin | |||||||||||||||
other names |
|
|||||||||||||||
Molecular formula | C 21 H 24 N 2 O 3 | |||||||||||||||
External identifiers / databases | ||||||||||||||||
|
||||||||||||||||
Drug information | ||||||||||||||||
ATC code | ||||||||||||||||
properties | ||||||||||||||||
Molar mass | 352.43 g mol −1 | |||||||||||||||
Physical state |
firmly |
|||||||||||||||
Melting point |
258 ° C |
|||||||||||||||
solubility |
bad in water |
|||||||||||||||
safety instructions | ||||||||||||||||
|
||||||||||||||||
As far as possible and customary, SI units are used. Unless otherwise noted, the data given apply to standard conditions . |
Ajmalicin , more precisely (-) - Ajmalicin (synonym: Raubasin ), is an indole alkaloid from the roots of the Indian snake root ( Rauvolfia serpentina ).
Pharmacological properties
Ajmalicin is an α1-adrenoceptor antagonist and, like reserpine, promotes peripheral blood flow, but without reducing blood pressure. It also has an anti-emetic effect. It is used medicinally in the adjuvant treatment of disorders of the peripheral arterial blood supply. Overdose can cause hypotension , tachycardia , dizziness, sweating, excitement, sedation and allergic skin reactions. Ajmalicin is of almost no therapeutic importance. In Germany, no monopreparations with this active ingredient are approved.
See also
Individual evidence
- ↑ a b DIMDI : ATC Classification Germany, 2019
- ↑ a b c d data sheet ajmalicin (PDF) from Carl Roth , accessed on February 5, 2013.
- ↑ E. Teuscher: Biogenic Medicines. 5th edition. Wissenschaftliche Verlagsgesellschaft, 1997. ISBN 3-8047-1482-X . P. 342.
- ↑ a b Summary of Product Characteristics: Lamuran , as of June 2005. Laboratorio Farmaceutico SIT Specialità Igienico Terapeutiche Srl (Italy)